Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

24.99 -0.01 (-0.04%)

Official Closing Price Updated: 7:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Nasdaq Navigates Choppy Waters: Tech Index Shows Resilience Amidst Volatility and AI Bubble Concerns

December 17, 2025

The Nasdaq Composite (IXIC) has been on a rollercoaster ride as 2025 draws to a close, experiencing a notable three-day losing streak before showing a modest rebound on December 17. This recent...

Via MarketMinute

The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now ↗

December 17, 2025

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.

Via The Motley Fool

Topics Intellectual Property

S&P Futures Gain as Investors Weigh U.S. Jobs Data, Fed Speak and Micron Earnings in Focus

December 17, 2025

December S&P 500 E-Mini futures (ESZ25) are trending up +0.27% this morning as investors continue to digest the latest U.S. jobs data, while also awaiting remarks from Federal Reserve officials and an...

Via Barchart.com

Topics Economy Government Stocks

Dow Jones Soars to New Highs Amidst Economic Crosscurrents and AI Jitters

December 17, 2025

New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new...

Via MarketMinute

Topics Artificial Intelligence Economy Government

obs Data Trips the Dow While AI Legislation Keeps Nasdaq Awake ↗

December 17, 2025

A messy, shutdown-delayed jobs print pushed unemployment to a four-year high, oil slid to fresh multi-year lows, and energy stocks took the punch. Meanwhile, an AI-infrastructure permitting push in the...

Via Chartmill

Topics Artificial Intelligence Stocks

Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

December 16, 2025

TLRY, PFE, NFLX, LEN, TSLA were among the stocks seen trending amid investors on Tuesday, Dec. 16, 2025.

Via Benzinga

Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast ↗

December 16, 2025

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.

Via The Motley Fool

Topics Intellectual Property Stocks

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 16, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Is Monte Rosa Stock Trading Higher Today? ↗

December 16, 2025

Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi in advanced prostate cancer patients.

Via Benzinga

Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector

December 16, 2025

New York, NY – December 16, 2025 – Pfizer Inc. (NYSE: PFE) today delivered a sobering financial outlook for 2026, projecting revenue and adjusted earnings per share (EPS) that fell short of Wall...

Via MarketMinute

Topics Intellectual Property

Curious about the most active stocks on Tuesday? ↗

December 16, 2025

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

1 Bold Prediction for Viking Therapeutics in 2026 ↗

December 16, 2025

Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it.

Via The Motley Fool

Pfizer Stock On-Track For Worst Day In Over 8 Months As BofA Flags Faster Covid-19 Product Erosion ↗

December 16, 2025

The company now expects full year 2025 guidance of about $62 billion, to the lower end of its previous guidance of $61 to $64 billion and below an analyst estimate of $62.52 billion.

Via Stocktwits

These S&P500 stocks are moving in today's session ↗

December 16, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Deep Dive: Windlas Biotech Limited – A Pharmaceutical Growth Story

December 16, 2025

As of December 16, 2025, Windlas Biotech Limited (NSE: WINDLAS, BSE: 543403) stands as a significant player in India's burgeoning pharmaceutical sector, primarily recognized for its robust contract...

Via PredictStreet

Topics Initial Public Offering

Pfizer Shares Fall As 2026 Outlook Reflects Weaker COVID-19 Drug Demand ↗

December 16, 2025

Pfizer shares fell after the company issued weaker-than-expected 2026 guidance, citing lower demand for COVID-19 products and upcoming patent expirations.

Via Talk Markets

Topics Intellectual Property

These S&P500 stocks are gapping in today's session ↗

December 16, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise' ↗

December 16, 2025

Pfizer issued a light outlook for 2026 on Tuesday, missing Wall Street's earnings forecast following a suite of acquisitions.

Via Investor's Business Daily

Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts ↗

December 16, 2025

Pfizer previews 2026 guidance with earnings below consensus, softer sales outlook, COVID decline and LOE headwinds offset by pipeline growth.

Via Benzinga

Pfizer Adds to Its Big Bet on Weight Loss Drugs ↗

December 16, 2025

Via MarketBeat

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

December 16, 2025

From Pfizer Inc.

Via Business Wire

Where Will Eli Lilly Be in 10 Years? ↗

December 16, 2025

In a decade, Eli Lilly could be in the same place that Pfizer finds itself in today.

Via The Motley Fool

Topics Intellectual Property

These S&P500 stocks are the most active in today's session ↗

December 15, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst ↗

December 15, 2025

Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.

Via Benzinga

Topics Intellectual Property

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

December 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Will Dogecoin Reach $1 By the End of the Year? ↗

December 15, 2025

Dogecoin's price would need to rise more than seven-fold before the calendar turns to 2026.

Via The Motley Fool

Topics Artificial Intelligence

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗

December 14, 2025

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Via The Motley Fool

Topics Intellectual Property

Forget Teladoc and Buy This Healthcare Stock Instead ↗

December 13, 2025

It's time for investors to give up on the telemedicine leader.

Via The Motley Fool

Rigani Press Announces Barnes & Noble Book Signing for Dr. S. Yin Ho's Groundbreaking Book

December 12, 2025

Via PRLog

Topics Artificial Intelligence

Pfizer Declares First-Quarter 2026 Dividend

December 12, 2025

From Pfizer Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.